ConductScience.org, home

Paper34818481

New Horizons in the Treatment of Osteosarcoma.

Meltzer PS and 1 other. N Engl J Med, 2021. Cited by 544 papers, by iCite.

Cite this record

ConductScience Library. New Horizons in the Treatment of Osteosarcoma. Papers, record 34818481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34818481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New Horizons in the Treatment of Osteosarcoma.
PubMed
Journal
N Engl J Med
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
544
iCite
Relative citation ratio, by iCite
31.9
iCite
Revised in PubMed
2021-12-14
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Meltzer PSPaul Shttps://orcid.org/0000-0003-0963-1768
2Helman LJLee J

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Bone NeoplasmsMajor topic
ImmunotherapyMajor topic
OsteosarcomaMajor topic
Humans
Neoadjuvant Therapy
Precision Medicine
Prognosis
Survival Rate

Source PubMed

Download CSV of topics

Cited by413

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 544 citations.

PMIDTitleJournalYearIn PapersSource
42967266FBXO17 promotes osteosarcoma progression by regulating glycolysis and macrophage polarization.J Mol Histol2026https://conductscience.org/library/papers/42967266PubMed
42900185Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300.J Exp Med2026https://conductscience.org/library/papers/42900185PubMed
42876757Pathological mechanisms of long non-coding RNA FOXD2-AS1 promoting osteosarcoma mediated by the COI-1/OCN/Runx-2 signaling pathway.Front Med (Lausanne)2026https://conductscience.org/library/papers/42876757PubMed
42864811A Living Multi-Omics PDX Biobank of High-Risk Sarcomas Reveals ecDNA-Driven Oncogene Amplification in Osteosarcoma and Enables Preclinical Precision Oncology.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42864811PubMed
42845418Integrated multi-omic analysis of pediatric metastatic osteosarcoma reveals endothelial cell plasticity and lineage infidelity.bioRxiv2026https://conductscience.org/library/papers/42845418PubMed
42826198An immunocompetent, multifluorescent resource for real-time analysis of osteosarcoma progression, metastasis, and response to therapy.Sci Adv2026https://conductscience.org/library/papers/42826198PubMed
42798652Integrative single-cell and bulk transcriptomics uncovers a lipid metabolism-related lncRNA signature alongside the ELFN1-AS1/LYPLA1 axis driving osteosarcoma progression.Front Immunol2026https://conductscience.org/library/papers/42798652PubMed
42795789Osteosarcoma Across the Age Spectrum: Why Outcomes Diverge and Trials Must Adapt.J Clin Med2026https://conductscience.org/library/papers/42795789PubMed
42787737Nutritional biomarkers regulating tumor immune microenvironment in osteosarcoma and as predictors of immune checkpoint inhibitor responses.Front Immunol2026https://conductscience.org/library/papers/42787737PubMed
42779977Clustered structural variant hotspots enable oncogenic addiction and plasticity in osteosarcoma.bioRxiv2026https://conductscience.org/library/papers/42779977PubMed
42769412Rule-derived preoperative inflammatory-lymphocyte recovery phenotype and pathological response in resected osteosarcoma: a retrospective cohort study.Front Immunol2026https://conductscience.org/library/papers/42769412PubMed
42723688Pulmonary metastasectomy and response-adapted preoperative surveillance in resectable metastatic osteosarcoma: a single-center retrospective cohort study with long-term follow-up.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42723688PubMed
42662799A universal consuming endogenous H2S strategy using bismuth-metal-organic nanocapsule networks for overcoming osteosarcoma cisplatin resistance.Bioact Mater2027https://conductscience.org/library/papers/42662799PubMed
42662506LNP-mediated silencing of oncogenic lncRNA PVT1 enhances chemotherapeutic efficacy in osteosarcoma.Biochem Biophys Rep2026https://conductscience.org/library/papers/42662506PubMed
42652069Integrated Bulk and Single-Cell Transcriptomics Reveals the C3-C3AR1 Axis as a Candidate Mediator of Coagulome-Immune Crosstalk in Osteosarcoma.Biomedicines2026https://conductscience.org/library/papers/42652069PubMed
42647168Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma.Cell Rep2026https://conductscience.org/library/papers/42647168PubMed
42601728Potential protective function and causal association of LEPR in osteosarcoma: An integrated bioinformatics analysis and Mendelian randomization study.Medicine (Baltimore)2026https://conductscience.org/library/papers/42601728PubMed
42591213MiRNA-140-3p affects the proliferation and metastasis of osteosarcoma via the UBE2C/PI3K-Akt axis.Front Oncol2026https://conductscience.org/library/papers/42591213PubMed
42566622The efficacy of whole-course nursing on malignant bone and soft tumors of lower limbs: A randomized study.Medicine (Baltimore)2026https://conductscience.org/library/papers/42566622PubMed
42565568Targeting ABCB6 induces ferroptosis in osteosarcoma cells via HIF1A/GPX4 pathway.Zhong Nan Da Xue Xue Bao Yi Xue Ban2026https://conductscience.org/library/papers/42565568PubMed

See all 413 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34818481

GET https://conductscience.org/api/papers/v1/34818481/cited_by?page=2